Breakthrough Discovery Identifies Protein 'Cloaking Device' in HPV-Linked Tumors; Blocking It Restores Immune Attack

Researchers at MSU and Henry Ford Health discovered that blocking the MARCHF8 protein makes invisible HPV-positive tumors vulnerable to immune attack.

By: AXL Media

Published: Mar 19, 2026, 7:27 AM EDT

Source: Information for this report was sourced from Michigan State University College of Human Medicine

Unmasking the Invisibility Mechanism of HPV-Positive Cancers

For years, a specific subset of head and neck cancers associated with the Human Papillomavirus (HPV) has baffled oncologists by their ability to evade the body's natural defenses. These tumors often lack MHCI molecules—the essential "red flags" that cells use to signal distress to the immune system. A new study published in the Proceedings of the National Academy of Sciences (PNAS) has finally identified the culprit: a protein called MARCHF8. Researchers discovered that HPV co-opts this protein to dismantle the cell's signaling markers before the immune system can recognize the threat, effectively acting as a biological cloaking device.

Turning 'Cold' Tumors 'Hot' via Genetic Intervention

The research team, led by Dr. Dohun Pyeon, demonstrated that by knocking out the MARCHF8 protein, the immune system's visibility was immediately restored. The results were described as "striking," as immune cells such as CD8+ T cells and natural killer (NK) cells—which had previously ignored the cancer—rapidly infiltrated the tumor microenvironment. This shift turns "cold" tumors, which typically resist standard immunotherapy, into "hot" tumors where the immune system can prevail. This breakthrough offers a potential lifeline for patients with late-stage or treatment-resistant head and neck cancers who currently have no other viable options.

High-Resolution Mapping of Immune Cell Crosstalk

To understand the precise mechanics of this recovery, the team utilized single-cell RNA sequencing to map the tumor microenvironment at an unprecedented resolution. Dr. Qing-Sheng Mi, a co-principal investigator, noted that removing MARCHF8 does more than just restore markers; it fundamentally rewires how immune cells communicate. The data showed a dramatic boost in the cytotoxic (cell-killing) activity of both T cells and NK cells, providing a clear blueprint of how the therapy works. This high-resolution mapping confirms that the treatment doesn't just stop the cancer from hiding—it actively recruits a more aggressive immune response.